Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8538956 | 0.90 | SOAT1 (0.40) | MAPTKDM4EMEN1KMT2AEGFR | |
| SCHEMBL8542206 | 0.84 | SOAT1 (0.41) | MAPTPOLBMAT2ANPC1RAB9A | |
| SCHEMBL8545691 | 0.82 | KDM4E (0.39) | MAPTKDM4EMEN1KMT2AEGFR | |
| SCHEMBL8543688 | 0.80 | SOAT1 (0.38) | MAPTKDM4EMEN1KMT2APOLB | |
| SCHEMBL8542487 | 0.80 | SOAT1 (0.40) | MAPTMEN1KMT2APOLB | |
| SCHEMBL8540781 | 0.80 | KDM4E (0.36) | KDM4EMEN1KMT2AEGFRPOLB | |
| SCHEMBL8834832 | 0.80 | — | — | |
| SCHEMBL8544183 | 0.77 | POLB (0.37) | MAPTMEN1KMT2APOLBCHEK1 | |
| SCHEMBL8543771 | 0.77 | POLB (0.36) | MAPTKDM4EMEN1KMT2APOLB | |
| SCHEMBL8544128 | 0.76 | POLB (0.37) | MAPTPOLBNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2668163-B2 | — | — | 1997-10-27 | — | — | JP | claimed |
| US-5565472-A | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | PFIZER INC. (US) | 1996-10-15 | — | — | US | claimed |
| WO-1993015058-A1 | 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS | PFIZER INC. (US) | 1993-08-05 | — | — | WO | claimed |
| EP-0623112-B1 | 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | PFIZER (US) | 1998-12-30 | — | — | EP | disclosed |
| US-5565472-A | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | PFIZER INC. (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0623112-A1 | 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS | PFIZER INC. (US) | 1994-11-09 | — | — | EP | disclosed |
| WO-1993015058-A1 | 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS | PFIZER INC. (US) | 1993-08-05 | — | — | WO | disclosed |